Dec 30, 2025 03:34PM
Dec 19, 2025 04:31PM
Dec 18, 2025 12:34PM
Dec 3, 2025 06:09AM
Nov 20, 2025 06:18AM
Nov 17, 2025 06:51AM
Oct 28, 2025 07:50AM Cybin Inc (CYBN) Halted, News Pending
Oct 15, 2025 07:04AM
Oct 15, 2025 07:02AM
Sep 23, 2025 05:00PM
Aug 26, 2025 07:31AM
Aug 19, 2025 06:41AM
Jul 17, 2025 07:30AM
Jul 8, 2025 06:44AM Cybin Inc. (CYBN) PT Lowered to $70 at Canaccord Genuity
Jul 1, 2025 01:38PM
Jun 13, 2025 07:45AM
Jun 6, 2025 06:11AM
Jun 3, 2025 07:31AM
May 20, 2025 07:32AM
May 15, 2025 07:31AM
May 8, 2025 07:30AM Cybin Inc (CYBN) Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder
Apr 23, 2025 07:30AM
Feb 13, 2025 06:50AM
Feb 12, 2025 06:34AM
Jan 28, 2025 06:40AM
Jan 15, 2025 12:07PM
Nov 19, 2024 06:57AM
Nov 18, 2024 07:00AM Cybin Inc (CYBN) Reports Positive Phase 2 Data for CYB003
Nov 14, 2024 07:30AM
Nov 14, 2024 07:12AM
Oct 24, 2024 07:31AM
Oct 1, 2024 07:30AM
Sep 23, 2024 06:33AM
Sep 19, 2024 07:26AM
Aug 13, 2024 07:30AM Cybin Inc (CYBN) Completes FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program
Jun 11, 2024 07:32AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All